We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRoquefort Thera Regulatory News (ROQ)

Share Price Information for Roquefort Thera (ROQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.40
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.20 (4.651%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4.40
ROQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Suspension - Roquefort Therapeutics plc

2 May 2023 07:30

RNS Number : 0620Y
Official List
02 May 2023
 

NOTICE OF TEMPORARY SUSPENSION OF LISTING FROM THE OFFICIAL LIST

02/05/2023 07:30

TEMPORARY SUSPENSION

Roquefort Therapeutics plc

The Financial Conduct Authority ("the FCA") temporarily suspends the securities set out below from the Official List effective from 02/05/2023 07:30 at the request of the company:

Security Description

Listing Category

ISIN

Ordinary shares of 1p each; fully paid

Standard Shares

GB00BMDQ2T15 ● 

This notice has been issued by Issuer Management - 020 7066 8352.

NotesSEDOL numbers which are allocated by the London Stock Exchange as a Stock Exchange identifier may be found on their dealing notice.●Denotes the security is being admitted to trading on the London Stock Exchange, a Recognised Investment Exchange.†Denotes the security is also being admitted to trading on Aquis Stock Exchange, a Recognised Investment Exchange.#Denotes the security is also being admitted to trading on Euronext, a Recognised Investment Exchange. Denotes the security is also being admitted to trading on Cboe Europe, a Recognised Investment Exchange.^Denotes the security is also being admitted to trading on Shanghai-London Stock Connect, a Recognised Investment Exchange.*Denotes the security is also being admitted to trading on IPSX Prime, a Recognised Investment Exchange.Notices issued by the FCA in respect of admission of securities to the Official List must be read in conjunction with notices issued by the relevant Recognised Investment Exchange in respect of admission of securities to trading on its markets.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SUSNKBBKABKKCPK
Date   Source Headline
26th Apr 20247:00 amRNSAnnual Report & Financial Statements - 31 Dec 2023
5th Apr 20247:00 amRNSResponse to Share Price Movement
11th Mar 20247:00 amRNSPositive Results: Midkine mRNA and STAT-6 siRNA
6th Feb 20247:00 amRNSOperations Update
24th Nov 20237:00 amRNSChange of Auditor
6th Nov 20237:00 amRNSSignificant Mesodermal Killer Cell Milestone
27th Sep 20237:00 amRNSInterim Results to 30 June 2023
22nd Sep 202311:42 amRNSInvestor Presentation via Investor Meet Company
14th Aug 20237:00 amRNSExpansion of Patent Portfolio
7th Aug 20237:00 amRNSDevelopment of New Novel siRNA Therapeutics
2nd Aug 20237:00 amRNSDirector/PDMR Shareholding
12th Jul 202310:27 amRNSDirector/PDMR Shareholding
29th Jun 202310:05 amRNSResults of AGM
29th Jun 20237:00 amRNSAGM Statement
27th Jun 20237:00 amRNSInvestor Presentation via Investor Meet Company
26th Jun 20232:41 pmRNSDirector/PDMR Shareholding
26th Jun 202310:36 amRNSDirector/PDMR Shareholding
26th Jun 202310:00 amRNSDirector/PDMR Shareholding
22nd Jun 20237:00 amRNSRNA Medicine Shows In Vitro Anti-Cancer Efficacy
19th Jun 20237:00 amRNSAntibody Program Results & Orphan Drug Indication
13th Jun 20237:00 amRNSAnti-Cancer MDK mRNA - Positive in vitro Results
7th Jun 202310:11 amRNSRestoration of Trading
6th Jun 20237:00 amRNSNotice of Annual General Meeting
5th Jun 20237:00 amRNSAnnual Report & Financial Statements - 31 Dec 2022
2nd May 20237:56 amRNSSuspension of Trading Pending 2022 Annual Report
2nd May 20237:30 amRNSSuspension - Roquefort Therapeutics plc
13th Mar 20237:30 amRNSConfirmation of No Exposure to Silicon Valley Bank
8th Mar 20237:00 amRNSCreation of New Novel Family of mRNA Therapeutics
6th Mar 20237:00 amRNSFormation of Scientific Advisory Board
1st Mar 20237:00 amRNSCompany Presentation
21st Feb 20237:00 amRNSInvestor Presentation
20th Feb 20237:00 amRNSRandox Licence and Royalty Agreement
24th Jan 20237:00 amRNSMDK Oncology Antibodies Demonstrate In-Vivo Safety
18th Jan 20238:36 amRNSHolding(s) in Company
16th Jan 20237:00 amRNSAppointment of Auditor
9th Jan 20237:00 amRNSOperations Update
5th Dec 20228:07 amRNSPresentation of Midkine Oligonucleotide Program
1st Dec 20222:00 pmRNSResignation of Auditor
25th Oct 20227:00 amRNSMidkine Antibody Program - Festival of Biologics
11th Oct 20227:00 amRNSROQ Presents Study Results at the ESGCT Conference
28th Sep 20227:00 amRNSDirector/PDMR Shareholding
26th Sep 20222:30 pmRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSInterim Results to 30 June 2022
23rd Sep 20227:00 amRNSInterim Results to 30 June 2022
16th Sep 20228:00 amRNSInvestor Presentation
16th Sep 20227:01 amRNSBoard and Management Appointments
16th Sep 20227:00 amRNSAcquisition Completion, Admission & Voting Rights
15th Sep 202212:26 pmRNSNotice of Admission
13th Sep 202211:08 amRNSPublication of Prospectus
11th Aug 20227:00 amRNSPre-clinical Program & Transaction Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.